{"id":987507971,"date":"2025-10-28T13:08:33","date_gmt":"2025-10-28T13:08:33","guid":{"rendered":"https:\/\/hollandcapital.nl\/project\/semalytix-2\/"},"modified":"2025-10-28T13:08:33","modified_gmt":"2025-10-28T13:08:33","slug":"semalytix-2","status":"publish","type":"project","link":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/","title":{"rendered":"Semalytix"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#213564&#8243; background_enable_image=&#8221;off&#8221; background_position=&#8221;bottom_center&#8221; background_vertical_offset=&#8221;42%&#8221; background_blend=&#8221;soft-light&#8221; height=&#8221;30vh&#8221; custom_padding=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; min_height=&#8221;1002.2px&#8221; custom_margin=&#8221;||-53px|||&#8221; custom_padding=&#8221;57px||56px||false|&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;3_5,2_5&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; make_equal=&#8221;on&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; admin_label=&#8221;Team Section Title  &#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;1350px&#8221; custom_margin=&#8221;|auto|35px|auto|false|false&#8221; custom_padding=&#8221;||10px||false|false&#8221; custom_padding_tablet=&#8221;|||||true&#8221; custom_padding_phone=&#8221;0px||10px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; custom_css_main_element_last_edited=&#8221;on|tablet&#8221; custom_css_main_element_tablet=&#8221;margin-bottom:15px;&#8221; custom_css_main_element_phone=&#8221;margin-bottom:15px;&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato|700|||||||&#8221; text_text_color=&#8221;#243B66&#8243; text_font_size=&#8221;30px&#8221; text_line_height=&#8221;1em&#8221; header_font=&#8221;Lato|700|||||||&#8221; header_font_size=&#8221;33px&#8221; header_2_font=&#8221;Lato|700|||||||&#8221; header_2_text_align=&#8221;center&#8221; header_2_text_color=&#8221;#1a243f&#8221; header_2_font_size=&#8221;33px&#8221; custom_margin=&#8221;||7px||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||0px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;|0px|||false|false&#8221; custom_padding_tablet=&#8221;&#8221; custom_padding_phone=&#8221;|0px||0px|false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;30px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; header_2_text_align_tablet=&#8221;&#8221; header_2_text_align_phone=&#8221;left&#8221; header_2_text_align_last_edited=&#8221;on|desktop&#8221; header_2_font_size_tablet=&#8221;&#8221; header_2_font_size_phone=&#8221;30px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; header_2_line_height_tablet=&#8221;&#8221; header_2_line_height_phone=&#8221;34px&#8221; header_2_line_height_last_edited=&#8221;on|phone&#8221; custom_css_main_element=&#8221;width: fit-content;||position: relative;&#8221; custom_css_after=&#8221;position: absolute;||content: &#8221;;||right: 0;||top:40%;||width: 50px;||height: 1px;||background-color: var(&#8211;team-color);transform: translateY(-50%);&#8221; global_colors_info=&#8221;{}&#8221; custom_css_before_last_edited=&#8221;on|phone&#8221; custom_css_before_phone=&#8221;display:none;&#8221; custom_css_after_last_edited=&#8221;on|phone&#8221; custom_css_after_phone=&#8221;display:none;&#8221; header_2_line_height__hover_enabled=&#8221;off|desktop&#8221; custom_css_after_tablet=&#8221;position: absolute;||content: &#8221;;||right: 0;||top:40%;||width: 50px;||height: 1px;||background-color: var(&#8211;team-color);transform: translateY(-50%);&#8221;]<\/p>\n<p>Semalytix<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato||||||||&#8221; text_text_color=&#8221;#B68013&#8243; text_font_size=&#8221;16px&#8221; text_letter_spacing=&#8221;1px&#8221; width=&#8221;70%&#8221; custom_margin=&#8221;||8px||false|false&#8221; custom_margin_tablet=&#8221;||19px||false|false&#8221; custom_margin_phone=&#8221;||16px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||1px|||&#8221; custom_css_main_element=&#8221;color:var(&#8211;team-color);&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Semalytix provides an Agentic AI platform for the pharmaceutical industry.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png&#8221; title_text=&#8221;Semalytix&#8221; align=&#8221;right&#8221; align_tablet=&#8221;center&#8221; align_phone=&#8221;center&#8221; align_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;50%&#8221; custom_margin=&#8221;|-4px|17px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#EFEFEF&#8221; max_width=&#8221;1350px&#8221; custom_margin=&#8221;|auto||auto|false|false&#8221; custom_padding=&#8221;50px|65px|50px|65px|true|true&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato|700||on|||||&#8221; text_text_color=&#8221;#B68013&#8243; text_font_size=&#8221;16px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||19px||false|false&#8221; custom_margin_tablet=&#8221;||19px||false|false&#8221; custom_margin_phone=&#8221;||16px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||1px|||&#8221; custom_css_main_element=&#8221;color:var(&#8211;team-color);&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Introduction<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;In portfolio since October 2025&#8243; image_icon_background_color=&#8221;RGBA(255,255,255,0)&#8221; image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8221; icon_placement=&#8221;left&#8221; image_icon_width=&#8221;45%&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Lato||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;20px&#8221; custom_margin=&#8221;10px||15px||false|false&#8221; custom_css_blurb_title=&#8221;margin-top: -3px;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][et_pb_blurb title=&#8221;Healthcare&#8221; image_icon_background_color=&#8221;RGBA(255,255,255,0)&#8221; image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8221; icon_placement=&#8221;left&#8221; image_icon_width=&#8221;45%&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Lato||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;20px&#8221; custom_margin=&#8221;||15px|||&#8221; custom_css_blurb_title=&#8221;margin-top: -3px;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][et_pb_blurb title=&#8221;Venture  Growth&#8221; image_icon_background_color=&#8221;RGBA(255,255,255,0)&#8221; image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8221; icon_placement=&#8221;left&#8221; image_icon_width=&#8221;45%&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Lato||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;20px&#8221; custom_margin=&#8221;||15px|||&#8221; custom_css_blurb_title=&#8221;margin-top: -3px;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][et_pb_blurb title=&#8221;Add ons&#8221; image_icon_background_color=&#8221;RGBA(255,255,255,0)&#8221; image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8221; icon_placement=&#8221;left&#8221; image_icon_width=&#8221;45%&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Lato||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;20px&#8221; body_text_color=&#8221;#000000&#8243; custom_margin=&#8221;||-3px|||&#8221; custom_css_blurb_title=&#8221;margin-top: -3px;&#8221; disabled global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Praktische GGZ<\/li>\n<li>ad Astra<\/li>\n<li>&#8230;<\/li>\n<\/ul>\n<p>[\/et_pb_blurb][et_pb_blurb title=&#8221;semalytix.com&#8221; url=&#8221;https:\/\/semalytix.com\/&#8221; url_new_window=&#8221;on&#8221; image_icon_background_color=&#8221;RGBA(255,255,255,0)&#8221; image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8221; icon_placement=&#8221;left&#8221; image_icon_width=&#8221;45%&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Lato||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;20px&#8221; custom_margin=&#8221;||15px|||&#8221; custom_css_blurb_title=&#8221;margin-top: -3px;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato|700||on|||||&#8221; text_text_color=&#8221;#B68013&#8243; text_font_size=&#8221;16px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||8px||false|false&#8221; custom_margin_tablet=&#8221;||19px||false|false&#8221; custom_margin_phone=&#8221;||16px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||1px|||&#8221; custom_css_main_element=&#8221;color:var(&#8211;team-color);&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>About Semalytix<\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_id=&#8221;module2-css-class&#8221; module_class=&#8221;module2-css-class&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; link_text_color=&#8221;#B68013&#8243; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#000000&#8243; text_orientation=&#8221;justified&#8221; custom_margin=&#8221;-2px||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Semalytix GmbH is based in Bielefeld, Germany, and provides an Agentic AI platform for the pharmaceutical industry. The PatientGPT-powered Atlas platform enables pharmaceutical teams to access the global \u2018patient voice\u2019 in a compliant manner and increasingly build, deploy and manage a library of proprietary, custom AI models. This \u2018Agent-as-a-Service\u2019 model makes it possible to embed patient intelligence directly into workflows, a crucial capability given that an estimated 75\u201385% of pharmaceutical workflows contain tasks that can be automated or supported by AI agents. In addition, this model helps companies build lasting intellectual property. This shifts the focus from temporary research to the creation of sustainable, strategic assets.    <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato|700||on|||||&#8221; text_text_color=&#8221;#B68013&#8243; text_font_size=&#8221;16px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||8px||false|false&#8221; custom_margin_tablet=&#8221;||19px||false|false&#8221; custom_margin_phone=&#8221;||16px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||1px|||&#8221; custom_css_main_element=&#8221;color:var(&#8211;team-color);&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Why do we invest in Semalytix?<\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_id=&#8221;module2-css-class&#8221; module_class=&#8221;module2-css-class&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#000000&#8243; link_text_color=&#8221;#B68013&#8243; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#000000&#8243; text_orientation=&#8221;justified&#8221; custom_margin=&#8221;-2px||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Jan-Frens van Giessel, Partner Healthcare at Holland Capital, commented: &#8220;Semalytix addresses a clear and growing need in the Pharma market with its unique AI technology capable of delivering scalable, real-time patient insights. We are impressed by the company&#8217;s strong commercial traction, highly defensible technology, and the ambitious vision of the founding team. Holland Capital is excited to partner with Semalytix and leverage our experience to support their journey in becoming a global leader in AI-powered patient intelligence.&#8221;<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/hollandcapital.nl\/semalytix-haalt-e57-miljoen-groeikapitaal-op-om-ai-platform-voor-patientinzichten-verder-op-te-schalen\/&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Lees hier het persbericht&#8221; button_alignment=&#8221;left&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#213564&#8243; button_bg_color=&#8221;#B68013&#8243; button_border_color=&#8221;RGBA(255,255,255,0)&#8221; button_border_radius=&#8221;3px&#8221; button_font=&#8221;Lato|900|||||||&#8221; button_icon=&#8221;\uf105||fa||900&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;50px|auto||auto||&#8221; custom_padding=&#8221;||10px|||&#8221; disabled locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|900|||||||&#8221; text_text_color=&#8221;#213564&#8243; text_font_size=&#8221;35px&#8221; text_line_height=&#8221;1.1em&#8221; text_orientation=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: center;\">Add on<\/p>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#B68013&#8243; divider_weight=&#8221;4px&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; transform_translate_linked=&#8221;off&#8221; width=&#8221;11%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;-10px||||false|false&#8221; custom_padding=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_5,1_5,1_5,1_5,1_5&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;4&#8243; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;50%&#8221; width_last_edited=&#8221;on|phone&#8221; module_alignment=&#8221;center&#8221; min_height=&#8221;91.3px&#8221; custom_padding=&#8221;2px||50px|||&#8221; border_color_all=&#8221;#B68013&#8243; disabled locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/01\/logo-02.jpeg&#8221; title_text=&#8221;logo-02&#8243; url=&#8221;https:\/\/www.unpri.org\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;75%&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/01\/logo-04.jpeg&#8221; title_text=&#8221;logo-04&#8243; url=&#8221;https:\/\/nvp.nl\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;75%&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/10\/logo_BVK.png&#8221; title_text=&#8221;logo_BVK&#8221; url=&#8221;https:\/\/www.bvkap.de\/home.html&#8221; url_new_window=&#8221;on&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/03\/3104587_1626073087104@1182&#215;1182-e1679564489848.jpeg&#8221; title_text=&#8221;3104587_1626073087104@1182&#215;1182&#8243; url=&#8221;https:\/\/nlcares.nl\/nl\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;86%&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/03\/IMCweekend_metstichting-02_EPS_kopie.jpg&#8221; title_text=&#8221;IMCweekend_metstichting-02_EPS_kopie&#8221; url=&#8221;https:\/\/www.imcweekendschool.nl\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;4px||100px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;11px|auto||auto|false|false&#8221; custom_padding=&#8221;2px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato|900|||||||&#8221; text_text_color=&#8221;#283583&#8243; text_font_size=&#8221;30px&#8221; text_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;||0px|||&#8221; animation_direction=&#8221;bottom&#8221; text_font_size_tablet=&#8221;40px&#8221; text_font_size_phone=&#8221;24px&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: center;\"><em>&#8220;<strong>&#8220;We are thrilled to welcome Holland Capital as our new partner. Their deep expertise in scaling technology and healthcare companies, demonstrated by their proven track record, including the recent successful exit of HealthConnected to Visma, combined with their strong network, will be invaluable as we enter our next phase of accelerated growth. We are also grateful for the continued trust and support from our existing investors.&#8221;  <\/strong><\/em><\/p>\n<p style=\"text-align: center;\"><strong>Janik Jaskolski, MSc, Co-Founder and CEO of Semalytix<\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;50px|auto||auto|false|false&#8221; custom_padding=&#8221;||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-website-2.png&#8221; height=&#8221;35vh&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-1.png&#8221; background_position=&#8221;top_center&#8221; background_vertical_offset=&#8221;27%&#8221; height=&#8221;35vh&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Sectie&#8221; module_id=&#8221;content&#8221; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#EFEFEF&#8221; custom_padding=&#8221;100px|0px|100px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|900|||||||&#8221; text_text_color=&#8221;#213564&#8243; text_font_size=&#8221;35px&#8221; text_line_height=&#8221;1.1em&#8221; text_orientation=&#8221;center&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p style=\"text-align: center;\">Healthcare portfolio<\/p>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#B68013&#8243; divider_weight=&#8221;4px&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; transform_translate_linked=&#8221;off&#8221; width=&#8221;11%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;-10px||||false|false&#8221; custom_padding=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-8px|auto||auto|false|false&#8221; custom_padding=&#8221;6px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_portfolio fullwidth=&#8221;off&#8221; posts_number=&#8221;4&#8243; include_categories=&#8221;43&#8243; show_title=&#8221;off&#8221; show_categories=&#8221;off&#8221; show_pagination=&#8221;off&#8221; zoom_icon_color=&#8221;RGBA(255,255,255,0)&#8221; hover_overlay_color=&#8221;RGBA(255,255,255,0)&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||-60px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_portfolio][et_pb_button button_url=&#8221;https:\/\/hollandcapital.nl\/portfolio\/&#8221; button_text=&#8221;ALL INVESTMENTS&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#B68013&#8243; button_border_color=&#8221;RGBA(255,255,255,0)&#8221; button_border_radius=&#8221;3px&#8221; button_font=&#8221;Lato|900|||||||&#8221; button_icon=&#8221;\uf105||fa||900&#8243; custom_margin=&#8221;55px||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#213564&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;60px||29px||false|false&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_5,1_5,1_5,1_5,1_5&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|6px|auto||&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Holland-capital-logo-wit.png&#8221; title_text=&#8221;Holland capital logo-wit&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; transform_translate_linked=&#8221;off&#8221; width=&#8221;91%&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin:auto;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin:auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_social_media_follow use_icon_font_size=&#8221;on&#8221; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#283583&#8243; button_bg_color=&#8221;#FFFFFF&#8221; button_border_color=&#8221;#FFFFFF&#8221; button_font=&#8221;|600|||||||&#8221; button_custom_margin=&#8221;||||false|false&#8221; button_custom_padding=&#8221;||||false|false&#8221; text_orientation=&#8221;left&#8221; background_layout=&#8221;dark&#8221; custom_margin=&#8221;||7px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_social_media_follow_network social_network=&#8221;linkedin&#8221; url=&#8221;https:\/\/www.linkedin.com\/company\/hollandcapital\/&#8221; icon_color=&#8221;#283583&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221; follow_button=&#8221;off&#8221; url_new_window=&#8221;on&#8221;]LinkedIn[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_5,1_5,1_5,1_5,1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|6px|auto||&#8221; custom_padding=&#8221;22px||6px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>Amsterdam<\/strong><\/span><br \/>Krijn Taconiskade 426<br \/>1087 HW Amsterdam<br \/>+31 (0) 20 3119411<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>D\u00fcsseldorf<\/strong><\/span><br \/><span>Inselstra\u00dfe 34<\/span><br \/><span>40479<\/span> D\u00fcsseldorf<br \/>+49 (0) 211 96290120<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.23&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; link_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#B68013&#8243;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>Contact<\/strong><\/span><br \/><a href=\"mailto:info@hollandcapital.nl\">info@hollandcapital.nl<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.18.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.20.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Lato||||||||solid&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; link_text_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;1px||||false|false&#8221; global_colors_info=&#8221;{}&#8221; link_text_color__hover_enabled=&#8221;on|hover&#8221; link_text_color__hover=&#8221;#B68013&#8243;]<\/p>\n<p style=\"text-align: left;\"><a href=\"https:\/\/hollandcapital.nl\/en\/privacy-verklaring\/\"><span>Privacy statement<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SemalytixSemalytix provides an Agentic AI platform for the pharmaceutical industry.Introduction Praktische GGZ ad Astra &#8230; About SemalytixSemalytix GmbH is based in Bielefeld, Germany, and provides an Agentic AI platform for the pharmaceutical industry. The PatientGPT-powered Atlas platform enables pharmaceutical teams to access the global \u2018patient voice\u2019 in a compliant manner and increasingly build, deploy and manage a library of proprietary, custom AI models. This \u2018Agent-as-a-Service\u2019 model makes it possible to embed patient intelligence directly into workflows, a crucial capability given that an estimated 75\u201385% of pharmaceutical workflows contain tasks that can be automated or supported by AI agents. In addition, this model helps companies build lasting intellectual property. This shifts the focus from temporary research to the creation of sustainable, strategic assets. Why do we invest in Semalytix?Jan-Frens van Giessel, Partner Healthcare at Holland Capital, commented: &#8220;Semalytix addresses a clear and growing need in the Pharma market with its unique AI technology capable of delivering scalable, real-time patient insights. We are impressed by the company&#8217;s strong commercial traction, highly defensible technology, and the ambitious vision of the founding team. Holland Capital is excited to partner with Semalytix and leverage our experience to support their journey in becoming a global leader [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":987507916,"comment_status":"open","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"project_category":[83,82],"project_tag":[],"class_list":["post-987507971","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-healthcare-en-2","project_category-venture-growth-en-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.6 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Semalytix- portfoliobedrijf Holland Capital<\/title>\n<meta name=\"description\" content=\"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semalytix\" \/>\n<meta property=\"og:description\" content=\"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Holland Capital\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/hollandcapital\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/\",\"name\":\"Semalytix- portfoliobedrijf Holland Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"datePublished\":\"2025-10-28T13:08:33+00:00\",\"description\":\"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"width\":320,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/project\\\/semalytix-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projecten\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Semalytix\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"name\":\"Holland Capital\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hollandcapital.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\",\"name\":\"Holland Capital Management BV\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"width\":186,\"height\":65,\"caption\":\"Holland Capital Management BV\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandcapital\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Semalytix- portfoliobedrijf Holland Capital","description":"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/","og_locale":"en_US","og_type":"article","og_title":"Semalytix","og_description":"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up","og_url":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/","og_site_name":"Holland Capital","article_publisher":"https:\/\/www.linkedin.com\/company\/hollandcapital\/","og_image":[{"width":320,"height":200,"url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/","url":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/","name":"Semalytix- portfoliobedrijf Holland Capital","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/#primaryimage"},"image":{"@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","datePublished":"2025-10-28T13:08:33+00:00","description":"Semalytix is a portfolio company of Holland Capital. Venture capital and growth - Health care - Growth financing - Investing in scale up","breadcrumb":{"@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/#primaryimage","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","width":320,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/hollandcapital.nl\/en\/project\/semalytix-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hollandcapital.nl\/"},{"@type":"ListItem","position":2,"name":"Projecten","item":"https:\/\/hollandcapital.nl\/project\/"},{"@type":"ListItem","position":3,"name":"Semalytix"}]},{"@type":"WebSite","@id":"https:\/\/hollandcapital.nl\/#website","url":"https:\/\/hollandcapital.nl\/","name":"Holland Capital","description":"","publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hollandcapital.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hollandcapital.nl\/#organization","name":"Holland Capital Management BV","url":"https:\/\/hollandcapital.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","width":186,"height":65,"caption":"Holland Capital Management BV"},"image":{"@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/hollandcapital\/"]}]}},"_links":{"self":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/project\/987507971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/comments?post=987507971"}],"version-history":[{"count":0,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/project\/987507971\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media\/987507916"}],"wp:attachment":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media?parent=987507971"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/project_category?post=987507971"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/project_tag?post=987507971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}